What went wrong for orthopedics at J&J MedTech and what might the future hold for the standalone DePuy Synthes?
The Numbers
Five things we’re watching as the orthopedic market’s competitive landscape evolves and we move into the second half of 2025.
Our chart of the month tracks spine M&A activity over the last decade, including the seven deals done so far in 2025.
Orthoflash®
SYNICEM antibiotic-loaded preformed spacers are designed to deliver a prolonged local concentration of gentamicin during two-stage revision procedures.
October 21, 2025
,
This marks the first 510(k) clearance for NanoCept Antibacterial Technology since the original De Novo authorization was granted in April 2024.
October 21, 2025
,
The range of spinal products and technologies provides a modular workflow for posterior stabilization and deformity correction.
October 20, 2025
,
ARKEO is designed to optimize fixation and graft integration through anatomical fit, open architecture, and controlled stability.
October 17, 2025
,
The Phase 3 trial is evaluating the single-injection biologic candidate for improvements in pain and function.
October 16, 2025
,
Competitive Landscape
ORTHOWORLD Experts talk you through market forecasts, company sales and key trends.
Industry Voices
